Head-to-head
Oak Longevity vs bmiMD
Compared on semaglutide across the eight dimensions this database records. They differ on 5 of those eight. bmiMD is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Oak Longevity is $133 a month all-in for semaglutide; bmiMD is $129. Over twelve months that is $1,596 against $1,188. Value Scores are 95.6 and 95.5 out of 100.
Semaglutide
Plan pages: Oak Longevity plans · bmiMD plans
At 2.4 mg/week, Oak Longevity is $133 a month all-in and bmiMD is $129 — $4 apart, or $48 across a year. Over twelve months the totals are $1,596 (billed monthly) and $1,188 (prepaid term).
Oak Longevity charges a flat $133 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
bmiMD charges a flat $129 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
| Dose | Oak Longevity | Rank | bmiMD | Rank | Cheaper |
|---|---|---|---|---|---|
| 0.25 mg | $133 | 4/32 | $129 | 2/32 | bmiMD by $4 |
| 0.5 mg | $133 | 3/21 | $129 | 1/21 | bmiMD by $4 |
| 1 mg | $133 | 3/21 | $129 | 1/21 | bmiMD by $4 |
| 1.7 mg | $133 | 3/21 | $129 | 1/21 | bmiMD by $4 |
| 2.4 mg | $133 | 3/29 | $129 | 1/29 | bmiMD by $4 |
bmiMD is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, Oak Longevity sits 2 of 29 on all-in monthly cost and bmiMD sits 1. They are adjacent in the field, with nothing priced between them. The field median is $249 and the floor is $129, so both sit below the median. Oak Longevity is $4 above the cheapest semaglutide program on record. bmiMD is the cheapest semaglutide program on record at this basis.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — Oak Longevity undercuts it by $216, bmiMD by $220. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Oak Longevity | bmiMD | Cheaper |
|---|---|---|---|
| Month to month | $133 | $129 | bmiMD by $4 |
| 3-month term | — | $119 | only bmiMD publishes this term |
| 6-month term | — | $109 | only bmiMD publishes this term |
| 12-month term | — | $99 | only bmiMD publishes this term |
| Settled dose | Oak Longevity | bmiMD | Difference |
|---|---|---|---|
| 0.25 mg | $1,596 | $1,548 | $48 apart |
| 0.5 mg | $1,596 | $1,548 | $48 apart |
| 1 mg | $1,596 | $1,548 | $48 apart |
| 1.7 mg | $1,596 | $1,548 | $48 apart |
| 2.4 mg | $1,596 | $1,548 | $48 apart |
Oak Longevity publishes no rate for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $1,596 on Oak Longevity and $1,548 on bmiMD. Both programs charge one flat rate, so the ramp costs the same as any other stretch of the year.
Value Scores are 95.6 for Oak Longevity and 95.5 for bmiMD, against a semaglutide category floor of $129. Oak Longevity leads by 0.1 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Oak Longevity | 67.9 | 12.8 | 10 | 5 | 95.6 |
| bmiMD | 70.0 | 10.5 | 10 | 5 | 95.5 |
Where the two programs differ
All-in monthly
bmiMD is cheaper month to month — $129 against $133, a gap of $4 every month, or $48 across a year if both rates hold.
Cancellation terms
Cancellation differs: Oak Longevity states Cancel before renewal, while bmiMD states Per provider terms; confirm cancellation policy at enrollment. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Oak Longevity asks for Month-to-month; bmiMD asks for Monthly, 3-month, 6-month, or 12-month plans; price varies by term, not by dose. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Evidence status
The two prices are not equally well evidenced. Oak Longevity's figure is provider-stated and bmiMD's is reported. Oak Longevity rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $1,596 for Oak Longevity and $1,188 for bmiMD. bmiMD is lower by $408 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Dose policy
Both hold one price across the whole dose ladder, so neither punishes titration and the monthly figures above are what you actually pay at 15 mg as well as at 2.5 mg.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Oak Longevity Official site
A small cash-pay telehealth program whose $133/month flat semaglutide price is currently the lowest month-to-month figure in our semaglutide index.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not publicly itemized), so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Availability confirmed at intake.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — First-party pricing page capture 2026-08-08
Watch: Small operator; pharmacy partner not publicly itemized. Price captured from the provider's published pages; checkout capture pending.
bmiMD Official site
bmiMD is a compounded GLP-1 telehealth platform notable for flat per-dose pricing — the rate stays the same whether you're at 2.5 mg or 15 mg — and one of the widest plan-tier menus in the market. Its $99/mo semaglutide and $139/mo tirzepatide on the twelve-month plan are the lowest annualized figures in the dataset for both molecules.
It does not publicly name its compounding pharmacy; the record shows Named 503A pharmacy partner (specific pharmacy not publicly identified on pricing page), so who actually makes the medication cannot be independently verified; commitment terms are Monthly, 3-month, 6-month, or 12-month plans; price varies by term, not by dose; cancellation is Per provider terms; confirm cancellation policy at enrollment; availability is stated as Availability at enrollment; confirm your state at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com cheapest-compounded-tirzepatide-online, capture verified 2026-07-14
Watch: bmiMD's 12-month semaglutide plan at $99/mo is the lowest annualized sema figure in our dataset, beating NexLife's $119/mo and Oak's $133 m2m. Month-to-month sema at $129 also beats Oak's $133, making bmiMD the new m2m sema leader. Tirzepatide 12-month at $139 ties NexLife. Figures are reported status from RangeYourself's July 2026 first-party captures; our independent checkout is pending.
Which molecules each one carries
Oak Longevity carries semaglutide at $133 a month; does not offer tirzepatide.
bmiMD carries tirzepatide at $179 a month and semaglutide at $129 a month.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
Oak Longevity does not publish
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Availability confirmed at intake
bmiMD does not publish
- no named compounding pharmacy
- no state-by-state availability list — it says Availability at enrollment; confirm your state at intake
- no specific cancellation or refund terms
Ask Oak Longevity and bmiMD for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. bmiMD carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. bmiMD publishes a twelve-month rate of $99 a month against $129 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for semaglutide, bmiMD Official site wins this matchup. And if you would rather trust a better-evidenced number, oak longevity's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. Oak Longevity's semaglutide price is provider-stated as of 2026-08-08; bmiMD's is reported as of 2026-07-14.
Questions
Is Oak Longevity or bmiMD cheaper for semaglutide?
bmiMD is cheaper on all-in monthly cost at 2.4 mg/week: $129 against $133, a difference of $4 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Oak Longevity versus bmiMD?
Oak Longevity works out to $1,596 across twelve months and bmiMD to $1,188, on the plan terms each publishes.
Does Oak Longevity or bmiMD raise the price as the dose goes up?
Oak Longevity: no, it charges one flat rate at every dose. bmiMD: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Oak Longevity and bmiMD differ?
5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Oak Longevity and bmiMD names its pharmacy?
Neither. Oak Longevity records Partner 503A pharmacy (not publicly itemized) and bmiMD records Named 503A pharmacy partner (specific pharmacy not publicly identified on pricing page). Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the Oak Longevity and bmiMD prices?
Oak Longevity's semaglutide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-08. bmiMD's is reported, captured 2026-07-14. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: Oak Longevity official site · bmiMD official site. Compounded tirzepatide and semaglutide are not FDA-approved products.